Business Wire

Q2, FY 2021 Results: Mytheresa Continues Strong Growth and Profitability

Share

MYT Netherlands Parent B.V. (NYSE:MYTE) (“Mytheresa” or the “Company”), the parent company of Mytheresa Group GmbH, today announced financial results for its fiscal second quarter ended December 31, 2020.

Michael Kliger, Chief Executive Officer of Mytheresa, said, “Even considering clear tailwinds by the COVID pandemic, the strong results of the second quarter of fiscal year 2021 confirm once more our strategy and unique business model: Mytheresa is about inspiration not aggregation. It is about an unrivaled, highly curated offering, a focus on high-end luxury customers, sophisticated technologies and a first-class in-house managed service experience.”

Kliger continued, “Our full commitment to acquire and retain the best customer base in the market creates a reinforcing cycle of outstanding brand relationships that feed a superior customer value proposition to generate strong customer economics, which allows us to stay true to our strategic focus. Therefore, we will continue to deliver growth as well as profitability.”

FINANCIAL HIGHLIGHTS FOR THE SECOND QUARTER ENDED DECEMBER 31, 2020

  • Net sales increase of 32.9% year-over-year to €158.6 million
  • Active customer growth of 28.2% to 569,000
  • Gross margin of 49.5%, a slight increase of 60 basis points year-over-year
  • Adjusted EBITDA of €22.1 million, as compared to €12.9 million in the prior year period
  • Adjusted EBITDA margin of 14.0%, as compared to 10.8% in the prior year period
  • Operating income of €16.6 million, as compared to €7.3 million in the prior year period
  • Adjusted operating income of €20.1 million, as compared to €10.9 million in the prior year period
  • Net income of €15.7 million, as compared to €6.3 million in the prior year period
  • Adjusted net income of €14.8 million, as compared to €6.4 million in the prior year period
  • Successfully completed IPO in January 2021 to raise proceeds, net of underwriting discounts and before related expenses of approximately $344.2 million

FINANCIAL HIGHLIGHTS FOR THE SIX MONTHS ENDED DECEMBER 31, 2020

  • Net sales increase of 30.4% year-over-year to €285.0 million
  • Gross margin of 48.2%, a slight increase of 20 basis points year-over-year
  • Adjusted EBITDA of €32.6 million, as compared to €17.2 million in the prior year period
  • Adjusted EBITDA margin of 11.4%, as compared to 7.9% in the prior year period
  • Operating income of €24.8 million, as compared to €8.9 million in the prior year period
  • Adjusted Operating income of €28.5 million, as compared to €13.4 million in the prior year period.
  • Net income of €25.4 million, as compared to €2.0 million in the prior year period
  • Adjusted net income of €20.1 million, as compared to €10.0 million in the prior year period

RECENT BUSINESS HIGHLIGHTS

  • Maintained business continuity in all operations with focus on health and well-being of all Mytheresa employees as top priority since the pandemic started
  • Record number of daily shipments, processing 11,000 parcels in just one day during Q2, FY 2021
  • Record high of first time buyers (over 100,000 new customers) in Q2, FY 2021
  • Further decreased customer acquisition costs
  • Significant increase in customer satisfaction with a Net Promoter Score of 87% in Q2, FY 2021
  • Continued expansion of the Mytheresa menswear business above expectations with net sales share surpassing 10% in December 2020
  • Hosted digital events targeting top customers in collaboration with the designers of Khaite, Wardrobe NYC, Eera, selected influencers and a physical VIC event in Shanghai, China in December 2020
  • Strong ongoing support of brand partners with the launch of exclusive capsule collections and pre-launches in collaboration with Valentino, Moncler, Dolce & Gabbana, Loewe, Christian Louboutin, Max Mara and many more

SUBSEQUENT EVENTS

On January 25, 2021, Mytheresa successfully closed its initial public offering (“IPO”) of 17,994,117 American Depositary Shares (“ADSs”), representing 17,994,117 ordinary shares, including the full exercise by the underwriters of their option to purchase 2,347,058 additional ADSs, representing 2,347,058 ordinary shares, at a public offering price of $26.00 per ADS. The Company sold 14,233,823 ADSs in the offering and its sole shareholder sold 3,760,294 ADSs in the offering, including 586,764 ADSs sold by the Company and 1,760,294 ADSs sold by the sole shareholder pursuant to the exercise in full of the underwriters’ option to purchase additional ADSs. The IPO raised approximately $344.2 million, net of underwriting discounts and before related expenses.

On January 26, 2021, Mytheresa exercised the option to repay the Fixed Rate Shareholder Loans (principal plus outstanding interest) with parts of the proceeds of our IPO, which resulted in cash outflows of €170.0 million ($ 206.6 million). In addition, MGG and its subsidiaries fully repaid any borrowings under the revolving credit facilities.

BUSINESS OUTLOOK

For the full fiscal year ending June 30, 2021, some of the beneficial performance tailwinds from COVID may be expected to slow down in Q3 and especially in Q4 as stores reopen. Nevertheless, we expect strong results for the full fiscal year in line with long-term expectations of net sales growth of low to mid-twenties and stable Adjusted EBITDA margins:

  • Net sales in the range of €565 million to €580 million, representing 26% to 29% growth
  • Adjusted EBITDA in the range of €45 million to €48 million, representing 27% to 36% growth
  • Adjusted EBITDA Margin of 8.0% to 8.3%

The foregoing forward-looking statements reflect Mytheresa’s expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially. Mytheresa does not intend to update its forward-looking statements until its next quarterly results announcement, other than in publicly available statements.

CONFERENCE CALL AND WEBCAST INFORMATION

Mytheresa will host a conference call to discuss its second quarter fiscal 2021 financial results on February 25, 2021 at 8:00am Eastern Time. Those wishing to participate via webcast should access the call through Mytheresa’s Investor Relations website at https://investors.mytheresa.com. Those wishing to participate via the telephone may dial in at +1 (833) 979-2860 (USA) or +1 (236) 714-2917 (International). A replay will be available via webcast through Mytheresa’s Investor Relations website. The telephone replay will be available from 11:00am Eastern Time on February 25, 2021, through March 4, 2021, by dialing +1 (800) 585-8367 (USA) or +1 (416) 621-4642 (International). The replay passcode will be 9993744.

FORWARD LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to the impact of the COVID-19 global pandemic; future sales, expenses, and profitability; future development and expected growth of our business and industry; our ability to execute our business model and our business strategy; having available sufficient cash and borrowing capacity to meet working capital, debt service and capital expenditure requirements for the next twelve months; and projected capital spending. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements are only predictions Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below.

We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make.

You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent our management’s beliefs and assumptions only as of the date such statements are made.

Further information on these and other factors that could affect our financial results is included in filings we make with the U.S. Securities and Exchange Commission (“SEC”) from time to time, including the section titled “Risk Factors” in our final prospectus under Rule 424(b) filed with the SEC on January 22, 2021 in connection with our IPO and 6-K (reporting our quarterly results). These documents are available on the SEC’s website at www.sec.gov and on the SEC Filings section of the Investor Relations section of our website at: https://investors.mytheresa.com.

ABOUT NON-IFRS FINANCIAL MEASURES

We review a number of operating and financial metrics, including the following business and non-IFRS metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. We present Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance. Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income have limitations, because they exclude certain types of expenses. Furthermore, other companies in our industry may calculate similarly titled measures differently than we do, limiting their usefulness as comparative measures. We use Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income as supplemental information only. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis.

Our non-IFRS financial measures include:

  • Adjusted EBITDA is a non-IFRS financial measure that we calculate as net income before finance expense (net), taxes, and depreciation and amortization, adjusted to exclude U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal 2020, IPO preparation and transaction costs and share-based compensation expenses.
  • Adjusted Operating Income is a non-IFRS financial measure that we calculate as operating income, adjusted to exclude U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal 2020, any IPO preparation and transaction costs and share-based compensation expenses.
  • Adjusted Net Income is a non-IFRS financial measure that we calculate as net income, adjusted to exclude U.S. sales tax expenditures temporarily borne by us, finance expenses on our Shareholder Loans, IPO preparation and transaction costs, share-based compensation expenses and related income tax effects.

ABOUT MYTHERESA

Mytheresa is one of the leading global luxury fashion e-commerce retailers. Mytheresa was launched in 2006 and offers ready-to-wear, shoes, bags and accessories for women, men and kids. The highly curated edit focuses on true luxury with designer brands such as Bottega Veneta, Burberry, Dolce & Gabbana, Fendi, Gucci, LOEWE, Loro Piana, Moncler, Prada, Saint Laurent, Valentino and many more. Mytheresa's unique digital experience is based on a sharp focus on high-end luxury shoppers, exclusive product and content offerings, leading technology and analytical platforms as well as high quality service operations.

For more information, please visit https://investors.mytheresa.com/.

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics
(Amounts in € millions)

 

Three Months Ended

 

Six Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

December
31, 2019

 

December
31, 2020

 

Change
in %

 

December
31, 2019

 

December
31, 2020

 

Change
in %

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

 

 

 

Active customer (LTM in thousands)

444

 

569

 

28.2%

 

444

 

569

 

28.2%

Total orders shipped (LTM in thousands)

1.010

 

1.256

 

24.4%

 

1.010

 

1.256

 

24.4%

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

€ 119.4

 

€ 158.6

 

32.9%

 

€ 218.5

 

€ 285.0

 

30.4%

Gross profit

€ 58.4

 

€ 78.6

 

34.6%

 

€ 104.7

 

€ 137.3

 

31.1%

Gross profit margin(1)

48.9%

 

49.5%

 

63 BPs

 

47.9%

 

48.2%

 

23 BPs

Adjusted EBITDA(2)

€ 12.9

 

€ 22.1

 

72.1%

 

€ 17.2

 

€ 32.6

 

89.1%

Adjusted EBITDA margin(1)

10.8%

 

14.0%

 

318 BPs

 

7.9%

 

11.4%

 

355 BPs

Adjusted Operating Income(2)

€ 10.9

 

€ 20.1

 

84.7%

 

€ 13.4

 

€ 28.5

 

113.3%

Adjusted Operating Income margin(1)

9.1%

 

12.7%

 

356 BPs

 

6.1%

 

10.0%

 

389 BPs

Adjusted Net Income(2)

€ 6.4

 

€ 14.8

 

131.4%

 

€ 10.0

 

€ 20.1

 

101.5%

Adjusted Net Income margin(1)

5.4%

 

9.3%

 

397 BPs

 

4.6%

 

7.0%

 

248 BPs

(1)

As a percentage of net sales.

(2)

EBITDA, adjusted EBITDA, adjusted Operating Income, adjusted net income are measures not defined under IFRS. For further information about how we calculate these measures and limitations of its use, see below.

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics
(Amounts in € millions)

The following are reconciliations of Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income to their most directly comparable IFRS measures:

 

Three Months Ended

Six Months Ended

 

 

 

 

 

 

 

 

December
31, 2019

December
31, 2020

Change
in %

December
31, 2019

December
31, 2020

Change
in %

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

Net income

€ 6.3

€ 15.7

148.4%

€ 2.0

€ 25.4

1,159.4%

Finance expenses, net

€ (3.4)

€ (5.0)

46.8%

€ 6.0

€ (10.2)

(269.7%)

Income tax expense

€ 4.4

€ 5.9

33.3%

€ 0.9

€ 9.6

1026.0%

Depreciation and amortization

€ 2.0

€ 2.0

3.0%

€ 3.9

€ 4.1

5.3%

thereof depreciation of right-of use

assets

€ 1.3

€ 1.3

2.3%

€ 2.5

€ 2.6

4.4%

EBITDA

€ 9.3

€ 18.7

100.1%

€ 12.7

€ 28.9

127.1%

U.S. sales tax(1)

€ 0.8

€ 0.0

(100.0%)

€ 1.7

€ 0.0

(100.0%)

IPO preparation and transaction costs(2)

€ 2.7

€ 3.5

27.9%

€ 2.7

€ 3.7

35.3%

Share-based compensation expense(3)

€ 0.0

€ 0.0

(68.2%)

€ 0.1

€ 0.0

(72.5%)

Adjusted EBITDA

€ 12.9

€ 22.1

72.1%

€ 17.2

€ 32.6

89.1%

 

Three Months Ended

 

Six Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

December
31, 2019

 

December
31, 2020

 

Change
in %

 

December
31, 2019

 

December
31, 2020

 

Change
in %

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

 

 

 

 

 

Operating Income

€ 7.3

 

€ 16.6

 

126.4%

 

€ 8.9

 

€ 24.8

 

180.3%

U.S. sales tax(1)

€ 0.8

 

€ 0.0

 

(100.0%)

 

€ 1.7

 

€ 0.0

 

(100.0%)

IPO preparation and transaction costs(2)

€ 2.7

 

€ 3.5

 

27.9%

 

€ 2.7

 

€ 3.7

 

35.3%

Share-based compensation expense(3)

€ 0.0

 

€ 0.0

 

(68.2%)

 

€ 0.1

 

€ 0.0

 

(72.5%)

Adjusted Operating Income

€ 10.9

 

€ 20.1

 

84.7%

 

€ 13.4

 

€ 28.5

 

113.3%

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics
(Amounts in € millions)

 

Three Months Ended

 

Six Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

December
31, 2019

 

December
31, 2020

 

Change
in %

 

December
31, 2019

 

December
31, 2020

 

Change
in %

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

 

 

 

 

 

Net Income

€ 6.3

 

€ 15.7

 

148.4%

 

€ 2.0

 

€ 25.4

 

1,156.4%

U.S. sales tax(1)

€ 0.8

 

€ 0.0

 

(100.0%)

 

€ 1.7

 

€ 0.0

 

(100.0%)

IPO preparation and transaction costs(2)

€ 2.7

 

€ 3.5

 

27.9%

 

€ 2.7

 

€ 3.7

 

35.3%

Share-based compensation expense(3)

€ 0.0

 

€ 0.0

 

(68.2%)

 

€ 0.1

 

€ 0.0

 

(72.5%)

Finance expenses on shareholder loans (4)

€ (3.7)

 

€ (5.3)

 

44.3%

 

€ 5.6

 

€ (10.9)

 

(296.1%)

Income tax effect(5)

€ 0.2

 

€ 0.9

 

338.9%

 

€ (2.1)

 

€ 1.9

 

(190.5%)

Adjusted Net Income

€ 6.4

 

€ 14.8

 

131.4%

 

€ 10.0

 

€ 20.1

 

101.5%

(1)

Represents expenses related to sales tax liabilities temporarily borne by us through the fourth quarter of fiscal 2020 in the United States. We temporarily incurred sales tax related liabilities on customer purchases in the United States because we were not able to charge our customers for these amounts at the point of sale under our previous IT configuration. Due to upgrades in our IT infrastructure during the fourth quarter of fiscal 2020, we no longer incur these expenses, as we charge the applicable U.S. sales tax directly to our customers.

(2)

Represents non-recurring professional fees, including consulting, legal and accounting fees, related to this offering, which are classified within selling, general and administrative expenses.

(3)

During the three and six months ended December 31, 2019 and 2020, respectively, certain key management personnel received share-based compensation from our ultimate parent. We do not consider these expenses to be indicative of our core operating performance.

(4)

Our Adjusted Net Income excludes finance expenses associated with our Shareholder Loans, which we do not consider to be indicative of our core performance. We did not receive any cash proceeds under the Shareholder Loans, which originated as part of the Neiman Marcus acquisition in 2014. Further, we do not have any financial covenants associated from the Shareholder Loans and we do not have any required interest or principal payments until their respective maturities in October 2025. In January 2021, we repaid our Shareholder Loans (principal plus outstanding interest) using a portion of the net proceeds from our initial public offering.

(5)

Reflects adjustments to historical income tax expense to reflect changes in taxable income for each of the periods presented due to changes in finance expenses related to the Shareholder Loans, assuming a statutory tax rate of 27.8%.

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Profit and Comprehensive Income
(Amounts in € thousands, except share and per share data)

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

 

 

 

(in € thousands)

 

December
31, 2019

December
31, 2020

 

December
31, 2019

 

December
31, 2020

 

 

 

 

 

 

 

 

Net sales

 

119,369

158,593

 

218,481

 

284,952

Cost of sales, exclusive of depreciation and amortization

 

(60,989)

(80,023)

 

(113,755)

 

(147,701)

Gross profit

 

58,380

78,570

 

104,726

 

137,251

Shipping and payment cost

 

(14,204)

(17,833)

 

(27,345)

 

(32,666)

Marketing expenses

 

(17,294)

(19,696)

 

(33,110)

 

(37,137)

Selling, general and administrative expenses

 

(17,839)

(22,104)

 

(31,794)

 

(37,660)

Depreciation and amortization

 

(1,987)

(2,046)

 

(3,864)

 

(4,067)

Other expense (income), net

 

284

(276)

 

244

 

(897)

Operating income

 

7,340

16,615

 

8,857

 

24,824

Finance (expense) income, net

 

3,389

4,975

 

(5,984)

 

10,157

Income (loss) before income taxes

 

10,729

21,590

 

2,873

 

34,981

Income tax expense (income)

 

(4,399)

(5,866)

 

(855)

 

(9,627)

Net income (loss)

 

6,330

15,724

 

2,018

 

25,354

Cash Flow Hedge

 

436

78

 

(846)

 

949

Income Taxes related to Cash Flow Hedge

 

(121)

11

 

235

 

(231)

Other comprehensive income (loss)

 

315

89

 

(611)

 

718

Comprehensive income (loss)

 

6,645

15,813

 

1,407

 

26,072

 

 

 

 

 

 

 

 

Basic and diluted earnings per share

0,09

0,22

0,03

0,36

Weighted average ordinary shares outstanding (basic and diluted)(1)

 

70,190,687

70,190,687

 

70,190,687

 

70,190,687

(1)

On January 12, 2021, the Company effected a 70,190,687 (with a nominal value per share of €0.000015) for one share split of its ordinary shares outstanding. Accordingly, all share and per share amounts for all periods presented in these condensed consolidated interim financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this share split.

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Financial Position
(Amounts in € thousands)

(in € thousands)

 

June 30, 2020

December 31, 2020

Assets

 

Non-current assets

 

Intangible assets and goodwill

 

154,966

154,883

Property and equipment, net

 

 

 

9,570

 

9,517

Right-of-use assets

 

19,001

16,298

Total non-current assets

 

183,537

180,698

Current assets

 

 

Inventories

 

 

 

169,131

 

231,968

Trade and other receivables

 

4,815

6,012

Other assets

 

 

 

18,950

 

18,180

Cash and cash equivalents

 

9,367

5,231

Total current assets

 

 

 

202,263

 

261,391

Total assets

 

385,800

442,089

 

 

Shareholders’ equity and liabilities

 

 

Subscribed capital

 

1

1

Capital reserve

 

 

 

91,008

 

91,022

Accumulated Deficit

 

(28,234)

(2,880)

Other comprehensive income

 

 

 

1,602

 

2,320

Total shareholders’ equity

 

64,377

90,463

 

 

Non-current liabilities

 

 

 

 

 

 

Shareholder Loans

 

191,194

174,651

Other liabilities

 

 

5,905

 

7,240

Tax liabilities

3,853

3,852

Provisions

 

 

582

 

706

Lease liabilities

13,928

11,338

Deferred tax liabilities, net

 

 

1,130

 

9,882

Total non-current liabilities

216,592

207,669

Current liabilities

 

 

 

 

 

Liabilities to banks

10,000

45,990

Lease liabilities

 

 

5,787

 

5,239

Contract liabilities

6,758

6,024

Trade and other payables

 

 

36,158

 

38,708

Other liabilities

46,128

47,996

Total current liabilities

 

 

104,831

 

143,957

Total liabilities

321,423

351,626

Total shareholders’ equity and liabilities

 

 

385,800

 

442,089

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Changes in Equity
(Amounts in € thousands)

(in € thousands)

 

Subscribed
capital

 

Capital
reserve

 

Accumulated
deficit

 

Hedging
reserve

 

Foreign currency
translation
reserve

 

Total
shareholders’
equity

Balance as of July 1, 2019

 

72

 

148,960

 

(34,584)

 

-

 

(3,128)

 

111,320

Net income

 

-

 

-

 

2,018

 

-

 

-

 

2,018

Other comprehensive income

 

-

 

-

 

-

 

(611)

 

1,224

 

613

Comprehensive income

 

-

 

-

 

2,018

 

(611)

 

1,224

 

2,631

Legal Reorganization

 

(71)

 

36,252

 

 

 

-

 

-

 

36,181

Share-based compensation

 

-

 

51

 

-

 

-

 

-

 

51

Balance as of December 31, 2019

 

1

 

185,263

 

(32,566)

 

(611)

 

(1.904)

 

150,183

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of July 1, 2020

 

1

 

91,008

 

(28,234)

 

-

 

1,602

 

64,377

Net income

 

-

 

-

 

25,354

 

-

 

-

 

25,354

Other comprehensive income

 

-

 

-

 

-

 

718

 

-

 

718

Comprehensive income

 

-

 

-

 

25,354

 

718

 

-

 

26,072

Share-based compensation

 

-

 

14

 

 

 

-

 

 

 

14

Balance as of December 31, 2020

 

1

 

91,022

 

(2,880)

 

718

 

1,602

 

90,463

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Cash Flows
(Amounts in € thousands)

Six months ended December 31,

(in € thousands)

2019

2020

 

Net (loss) income

 

 

 

2,018

 

25,354

Non-Cash items

 

 

 

 

 

 

Depreciation and amortization

 

 

 

3,864

 

4,067

Finance expense (income), net

 

 

 

5,984

 

(10,157)

Share-based compensation

 

 

 

51

 

14

Income tax (income) expense

 

 

 

855

 

9,627

Change in operating assets and liabilities

 

 

 

 

 

 

Increase in provisions

 

 

 

8

 

124

Increase in inventories

 

 

 

(36,418)

 

(62,837)

Decrease (increase) in trade and other receivables

 

 

 

1,499

 

(1,197)

Decrease (increase) in other assets

 

 

 

1,072

 

1,955

Increase in other liabilities

 

 

 

8,726

 

2,968

Increase (decrease) in contract liabilities

 

 

 

1,528

 

(734)

(Decrease) increase in trade and other payables

 

 

 

(7,949)

 

2,550

Income taxes paid

 

 

 

(1,723)

 

(1,102)

Net cash (outflow) from operating activities

 

 

 

(20,485)

 

(29,368)

Expenditure for property and equipment and intangible assets

 

 

 

(1,281)

 

(1,363)

Proceeds from sale of property and equipment and intangible assets

 

 

 

-

 

44

Net cash (outflow) from investing activities

 

 

 

(1,281)

 

(1,319)

Interest paid

 

 

 

(418)

 

(3,962)

Proceeds from bank liabilities

 

 

 

30,000

 

64,990

Repayment of liabilities from banks

 

 

 

(862)

 

(29,000)

Repayment of Shareholder loans

 

 

 

-

 

(2,411)

Lease payments

 

 

 

(2,465)

 

(3,047)

Net cash inflow from financing activities

 

 

 

26,255

 

26,570

Net increase (decrease) in cash and cash equivalents

 

 

 

4,489

 

(4,118)

Cash and cash equivalents at the beginning of the period

 

 

 

2,120

 

9,367

Effects of exchange rate changes on cash and cash equivalents

 

 

 

(28)

 

(18)

Cash and cash equivalents at end of the period

 

 

 

6,581

 

5,231

Contact information

Investor Relations Contacts
Ed Yuen / Maria Lycouris
+1-800-929-7167
investors@mytheresa.com

Media Contacts for public relations

Mytheresa.com GmbH
Sandra Romano
mobile: +49 152 54725178
phone: +49 89 127695-236
email: sandra.romano@mytheresa.com

Media Contacts for business press

Edelman USA
Ted McHugh / Nicole Briguet
phone: +1 201 341-0211 / +1 646 750-7235
email: ted.mchugh@edelman.com
email: nicole.briguet@edelman.com

Edelman Germany, Austria, Switzerland
Ruediger Assion
mobile: +49 162 4909624
phone: +49 221 8282 8111
email: ruediger.assion@edelmann.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BridgeTower Capital Launches Security Token Pre-Offering and Announces Global Expansion With Key Partners15.4.2021 19:00:00 EEST | Press release

BridgeTower Capital, a tokenized global private equity firm, has launched a private Security Token Pre-Offering (STO) culminating 12 months of work to purposefully assemble a team of world-class partners to participate in the blockchain infrastructure and services marketplace in the rapidly growing world of decentralized finance (DeFi). BridgeTower also announced it has formed a Zurich-based entity to further expand its current offering of blockchain infrastructure products and services. BridgeTower launched its Private -STO campaign earlier this week, which provides an opportunity for accredited investors to purchase shares in the company in the form of a digital security. BridgeTower has received active participation already and is seeking to raise $200 million in this initial raise. “We are seeing a global confluence of public and private digital finance markets being fueled by the adoption of blockchain technologies. This is creating unique opportunities for those who can assemble

Cryptology Asset Group p.l.c. successfully completes a share capital increase and sale of treasury shares and reviews options for financing further growth15.4.2021 17:49:00 EEST | Press release

Cryptology Asset Group p.l.c. (ISIN: MT0001770107; Ticker: CAP), a leading European investment company for blockchain- and crypto-related business models, has successfully completed its cash capital increase by issuing 128,375 new shares and the additional sale of the entire amount of 31,625 treasury shares to institutional investors. At a fixed price of EUR 200.00 per share each, the Company will receive total gross proceeds of EUR 32.0 million, which will be used to invest in new portfolio companies from the Cryptology pipeline. The Company is also exploring the possible acquisition of crypto assets, such as Bitcoin, as part of its treasury management strategy. To finance further growth, Cryptology is also currently reviewing various options to raise additional capital, such as through the issuance of a convertible or a straight bond. ICF BANK AG has been commissioned to conduct a market review. Management will make the final financing decision based on investor feedback and the prev

Cryptology Asset Group p.l.c. resolves a cash capital increase and sale of treasury shares15.4.2021 17:45:00 EEST | Press release

The Board of Directors of Cryptology Asset Group p.l.c. (ISIN: MT0001770107; Ticker: CAP) today resolved to increase the share capital of the Company by 128,375 new shares and to sell 31,625 treasury shares which is the entire position Cryptology holds of own shares after the buyback done over the last months. Shareholders' subscription rights to the new shares and the treasury shares are excluded. The Company has entered into binding subscription agreements for the entire amount of in total 160,000 shares with several institutional investors. Closing of the transaction is expected for end of April 2021. The capital increase will be carried out in cash contributions and by partially utilizing the existing authorized capital. The share capital of the Company is to be increased from EUR 2,732,500 to EUR 2,860,875 by issuing 128,375 new bearer shares of the Company ("New Shares"). The New Shares will be issued with a pro rata amount of capital stock of EUR 1.00 per share and with full div

A Digital Transformation: Mary Kay Inc. Launches Immersive Virtual Experience Platform Suite 13TM15.4.2021 16:03:00 EEST | Press release

Global beauty brand Mary Kay Inc. and its Mary Kay Global Design Studio present Suite 13TM, an innovative virtual beauty experience that leverages the use of virtual reality to digitize Mary Kay's first virtual pop-up showroom. Designed with the latest virtual reality technology, the new Suite 13TM offers Mary Kay Independent Beauty Consultants and their customers a 360-degree, 3D beauty experience where users can virtually browse the beauty brand’s portfolio of skin care as well as explore the company and its founder Mary Kay Ash’s history. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210415005306/en/ The new Suite 13™ offers Mary Kay Independent Beauty Consultants and their customers a 360-degree, 3D beauty experience. (Photo: Mary Kay Inc.) The new Suite 13TM invites users to tour through virtual “rooms”. Upon entering the “Lobby”, users can learn about the Company’s global legacy. The other virtual rooms include the “P

Conviva Works With ServiceNow to Provide Next Generation Customer Service for Streaming Customers15.4.2021 16:00:00 EEST | Press release

Conviva, the intelligence cloud for streaming media, today announced that its streaming insights data will be integrated with ServiceNow telecom and media industry solutions. This new integration will enable streaming providers to offer more reliable streaming services and personalized customer care experiences to drive user acquisition, reduce operational costs and increase customer lifetime value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210415005156/en/ Conviva and ServiceNow Provide Next Generation Customer Service For Streaming Customers (Graphic: Business Wire) Conviva’s integration with ServiceNow extends ServiceNow’s offerings within the telecom and media industry and will help streaming customers to automate proactive case creation and ticket generation to identify and diagnose incidents across the entire video delivery supply chain. Adding this additional layer of automation to root cause analysis delivers im

Thales IoT SAFE to Secure Cloud Connectivity for New Internet of Things Services in Canada15.4.2021 16:00:00 EEST | Press release

Thales technology is at the heart of a new Canadian IoT project that is enabling instant, secure and scalable cloud connectivity for SIM/eSIM-enabled IoT. Working alongside TELUS, a leading Canadian wireless network operator, and the Canadian Internet Registration Authority (CIRA), the project’s certification partner, Thales is supplying SIMs and the IoT server, both compliant with the GSMA IoT SAFE specifications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210415005017/en/ (Photo: Thales) The Thales IoT SAFE service offers an interoperable framework enabling swift deployment of IoT applications. Delivered in a plug & play SaaS mode, it benefits minimal integration effort. It creates a scalable and automatic environment for cloud data security of SIM-equipped devices with a remote management feature. TELUS continues its IoT expansion with devices across Canada, offering enterprises an innovative system that eliminates th

First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella15.4.2021 15:03:00 EEST | Press release

Abiomed (NASDAQ:ABMD) announced today that the first patient has been enrolled in PROTECT IV, a large, prospective, multi-center randomized controlled trial (RCT) that is designed to provide the level of clinical evidence needed to achieve a Class I guideline recommendation for Impella in high-risk percutaneous coronary intervention (HRPCI). The first patient was enrolled at Ascension St. John Hospital in Detroit by Dr. Ted Schreiber, chief of cardiology at Ascension St. John Macomb-Oakland Hospital and Dr. Amir Kaki, interventional cardiologist and director of mechanical circulatory support at Ascension St. John Hospital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210415005234/en/ Impella Clinical Pathway to Class I Guideline (Graphic: Business Wire) The two-arm trial will compare the benefits of HRPCI with Impella versus HRPCI without Impella support. The primary endpoint of the study is the composite of all-cause deat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom